[Skip to Navigation]
Comment & Response
May 2017

Hypertriglyceridemia and Pancreatitis—New Evidence That Less Is More—Reply

Author Affiliations
  • 1Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark
  • 2Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
JAMA Intern Med. 2017;177(5):745-746. doi:10.1001/jamainternmed.2017.0616

In Reply We would like to thank Lederle and Bloomfield for providing relevant comments in relation to our article1 on mild-to-moderate hypertriglyceridemia and risk of both acute pancreatitis and myocardial infarction. Lederle and Bloomfield suggest that based on our data the threshold for treating asymptomatic hypertriglyceridemia should be raised to 2000 mg/dL or treatment for this condition should be abandoned entirely. Of note, the goal of our article1 was to elucidate potential biological or pathological relationships, rather than to provide any specific advice on how to use our results to inform treatment guidelines.

Add or change institution